{"id":"09b22cf2-f9da-5233-a445-385bf6d28d18","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-glioma-cytotoxicity","predicate":"reduces","statement":"In glioblastoma cell lines mebendazole displayed cytotoxicity with half-maximal inhibitory concentrations ranging from 0.1 to 0.3 micromolar, disrupted microtubule formation in those cells with in vitro activity correlated with reduced tubulin polymerization, and significantly extended mean survival by up to 63% in syngeneic and xenograft orthotopic mouse glioma models; the programme began with the serendipitous observation that fenbendazole, used to treat pinworm infection, inhibited brain tumour engraftment.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"9e10c91b-3a50-5a52-8b42-d1895d349ec5","mechanism_event_label":"The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer.","subject":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"object":{"id":"83751ca3-e020-52f1-b775-bb614125e35e","slug":"glioma-cell-viability-mbz","display_name":"Viability of glioblastoma cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"9e10c91b-3a50-5a52-8b42-d1895d349ec5","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-glioma-cytotoxicity-event","event_type":"biochemical_relationship","label":"The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer.","description":"In glioblastoma cell lines mebendazole displayed cytotoxicity with half-maximal inhibitory concentrations ranging from 0.1 to 0.3 micromolar, disrupted microtubule formation in those cells with in vitro activity correlated with reduced tubulin polymerization, and significantly extended mean survival by up to 63% in syngeneic and xenograft orthotopic mouse glioma models; the programme began with the serendipitous observation that fenbendazole, used to treat pinworm infection, inhibited brain tumour engraftment.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"011e92dc-f29a-5ed1-bc3e-942ffc6664bb","slug":"microtubule-polymerisation","display_name":"Polymerisation of tubulin into microtubules","entity_type_key":"cellular_process"},"role":"disrupted_process","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"77f3f912-582a-5144-99ab-f66afe1bb548","slug":"fenbendazole","display_name":"Fenbendazole","entity_type_key":"drug"},"role":"originating_observation","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ace31cb7-2519-519c-aa9b-5ebdd5bf437e","slug":"orthotopic-glioma-survival","display_name":"Survival of mice bearing orthotopic glioma","entity_type_key":"cellular_process"},"role":"measured_endpoint","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"83751ca3-e020-52f1-b775-bb614125e35e","slug":"glioma-cell-viability-mbz","display_name":"Viability of glioblastoma cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/mebendazole-research/21764822.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6\", \"start_char\": 0, \"end_char\": 1210, \"text_sha256\": \"31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Mebendazole compared with fenbendazole, at doses documented as safe in humans","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The observation that started the programme was serendipitous, from pinworm treatment of laboratory animals. Mouse models, and the survival gain is a mean rather than a cure.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.","comparator":null,"unit":null,"notes":"","entity":{"slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human cells and mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mbz-p21764822] Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. (2011). https://pubmed.ncbi.nlm.nih.gov/21764822/ DOI: 10.1093/neuonc/nor077","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Glioblastoma","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"84447d57-0fb1-5bfa-aa4a-fd2e6964ca82","evidence_kind":"source_excerpt","locator":"Lines 485-496","start_line":485,"end_line":496,"excerpt":"### mbz-glioma-cytotoxicity\nIn glioblastoma cell lines mebendazole displayed cytotoxicity with half-maximal inhibitory concentrations ranging from 0.1 to 0.3 micromolar, disrupted microtubule formation in those cells with in vitro activity correlated with reduced tubulin polymerization, and significantly extended mean survival by up to 63% in syngeneic and xenograft orthotopic mouse glioma models; the programme began with the serendipitous observation that fenbendazole, used to treat pinworm infection, inhibited brain tumour engraftment.\nCondition category: normal\nnutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.\nplain_language: The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer.\norganism: Human cells and mouse\ntissue_or_cell_type: Glioblastoma\nexperimental_model: Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models\nlimitations: The observation that started the programme was serendipitous, from pinworm treatment of laboratory animals. Mouse models, and the survival gain is a mean rather than a cure.\nexposure: Mebendazole compared with fenbendazole, at doses documented as safe in humans\nevidence_span: {\"source_cache\": \"artifacts/mebendazole-research/21764822.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6\", \"start_char\": 0, \"end_char\": 1210, \"text_sha256\": \"31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6\"}\n[mbz-p21764822] Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. (2011). https://pubmed.ncbi.nlm.nih.gov/21764822/ DOI: 10.1093/neuonc/nor077","model_system":"Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mbz-p21764822] Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. (2011). https://pubmed.ncbi.nlm.nih.gov/21764822/ DOI: 10.1093/neuonc/nor077","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"06104773-03d0-5e5c-b9da-eb484e7be657","stable_key":"import-f2ec2007-88ff-5a96-a73b-8b5085e9cea9","title":"Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"58b652636677e5033fd1dd555744485fcef18f21a97dcf68723fe072b656f413","revision_id":"a2cd9c22-0549-52ca-a653-8a0c2362ec85","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}